REFERENCES

1. Gilbert MR. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches. Semin Oncol 2011;38:S21-33.

2. Vaupel P, Kelleher DK, Höckel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28:29-35.

3. Oliver L, Olivier C, Marhuenda F, Campone M, Vallette F. Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2009;2:263-84.

4. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance MDR1 gene. Cancer Res 2002;62:3387-94.

5. Weeks AJ, Paul RL, Marsden PK, Blower PJ, Lloyd DR. Radiobiological effects of hypoxia-dependent uptake of 64 Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. Eur J Nucl Med Mol Imaging 2010;37:330-8.

6. Ling CC, Humm J, Larson S, Amols H, Fuks Z, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.

7. Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, et al. 18F-fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging 2012;39:760-70.

8. Miyake K, Ogawa D, Okada M, Hatakeyama T, Tamiya T. Usefulness of positron emission tomographic studies for gliomas. Neurol Med Chir (Tokyo) 2016;56:396-408.

9. Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, et al. Imaging tumour hypoxia with positron emission tomography. Br J Cancer 2015;112:238-50.

10. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, et al. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.

11. Li F, Joergensen JT, Hansen AE, Kjaer A. Kinetic modeling in PET imaging of hypoxia. Am J Nucl Med Mol Imaging 2014;4:490-506.

12. Lim JL, Berridge MS. An efficient radiosynthesis of [18F]fluoromisonidazole. Appl Radiat Isot 1993;44:1085-91.

13. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-88.

14. Bruehlmeier M, Roelcke U, Schubiger PA, Ametamey SM. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. J Nucl Med 2004;45:1851-9.

15. McGowan DR, Skwarski M, Papiez BW, Macpherson RE, Gleeson FV, et al. Whole tumor kinetics analysis of 18F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow. EJNMMI Res 2018;8:73.

16. Bholowalia P, Kumar A. Ebk-means: a clustering technique based on elbow method and K-Means in WSN. Int J Comput Appl ;2014:105.

17. Wang Z, Bovik AC, Sheikh HR, Simoncelli EP. Image quality assessment: From error visibility to structural similarity. IEEE Trans Image Process 2004;13:600-12.

18. Syakur MA, Khotimah BK, Rochman EMS, Satoto BD. Integration K-means clustering method and elbow method for identification of the best customer profile cluster. IOP Conference Series: Materials Science and Engineering 2018; doi: 10.1088/1757-899X/336/1/012017.

19. Thorwarth D, Eschmann SM, Paulsen F, Alber M. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 2005;50:2209-24.

20. Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with 18F-FDG PET, 18F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 2009;50:1020-7.

21. Zips D, Zöphel K, Abolmaali N, Perrin R, Abramyuk A, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol 2012;105:21-8.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/